Jane Metrik1,2,3, Shayna S Bassett4, Elizabeth R Aston2, Kristina M Jackson2, Brian Borsari5,6. 1. Providence VA Medical Center, Providence, RI, 02908, USA. 2. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, 02903, USA. 3. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, 02912, USA. 4. Department of Psychology, Social Sciences Research Center, University of Rhode Island, Kingston, RI, 02881, USA. 5. San Francisco VA Medical Center, San Francisco, CA, 94121, USA. 6. Department of Psychiatry, University of California - San Francisco, San Francisco, CA, 94103, USA.
Abstract
BACKGROUND: Although increasing rates of cannabis use and cannabis use disorder (CUD) are well-documented among veterans, little is known about their use of cannabis specifically for medicinal purposes. The present study characterizes such use and compares veterans reporting cannabis use for medicinal (n = 66) versus recreational (n = 77) purposes on (a) sociodemographic factors, (b) psychiatric disorders (posttraumatic stress disorder [PTSD], major depressive disorder [MDD], and CUD), (c) other substance use, (d) reasons for cannabis use and cannabis-related problems, and (e) physical and mental health. METHODS: Participants were veterans deployed post 9/11/2001 recruited from a Veterans Health Administration (VHA) facility (N = 143; mean [SD] age = 30.0 [6.6]; mean [SD] deployments = 1.7 [1.1]) who reported past-year cannabis use. RESULTS: The most frequently endorsed conditions for medicinal cannabis (MC) use were anxiety/stress, PTSD, pain, depression, and insomnia. In logistic regression analyses adjusted for frequency of cannabis use, MC users were significantly more likely (OR = 3.16) to meet criteria for PTSD than recreational cannabis (RC) users. Relative to RC users, MC users reported significantly greater motivation for using cannabis to cope with sleep disturbance as well as significantly poorer sleep quality and worse physical health. CONCLUSIONS: Veterans who use cannabis for medicinal purposes differ significantly in sleep, physical and mental health functioning than veterans who use cannabis for recreational purposes. PTSD and sleep problems may be especially relevant issues to address in screening and providing clinical care to returning veterans who are using cannabis for medicinal purposes.
BACKGROUND: Although increasing rates of cannabis use and cannabis use disorder (CUD) are well-documented among veterans, little is known about their use of cannabis specifically for medicinal purposes. The present study characterizes such use and compares veterans reporting cannabis use for medicinal (n = 66) versus recreational (n = 77) purposes on (a) sociodemographic factors, (b) psychiatric disorders (posttraumatic stress disorder [PTSD], major depressive disorder [MDD], and CUD), (c) other substance use, (d) reasons for cannabis use and cannabis-related problems, and (e) physical and mental health. METHODS: Participants were veterans deployed post 9/11/2001 recruited from a Veterans Health Administration (VHA) facility (N = 143; mean [SD] age = 30.0 [6.6]; mean [SD] deployments = 1.7 [1.1]) who reported past-year cannabis use. RESULTS: The most frequently endorsed conditions for medicinal cannabis (MC) use were anxiety/stress, PTSD, pain, depression, and insomnia. In logistic regression analyses adjusted for frequency of cannabis use, MC users were significantly more likely (OR = 3.16) to meet criteria for PTSD than recreational cannabis (RC) users. Relative to RC users, MC users reported significantly greater motivation for using cannabis to cope with sleep disturbance as well as significantly poorer sleep quality and worse physical health. CONCLUSIONS: Veterans who use cannabis for medicinal purposes differ significantly in sleep, physical and mental health functioning than veterans who use cannabis for recreational purposes. PTSD and sleep problems may be especially relevant issues to address in screening and providing clinical care to returning veterans who are using cannabis for medicinal purposes.
Entities:
Keywords:
PTSD; cannabis; medical marijuana; sleep; veteran
Authors: Mohammadali Mojarrad; Jeffrey H Samet; Debbie M Cheng; Michael R Winter; Richard Saitz Journal: Drug Alcohol Depend Date: 2014-06-18 Impact factor: 4.492
Authors: Brian E Perron; Kipling Bohnert; Angela K Perone; Marcel O Bonn-Miller; Mark Ilgen Journal: J Stud Alcohol Drugs Date: 2015-05 Impact factor: 2.582
Authors: Kevin P Hill; Heather E Bennett; Margaret L Griffin; Hilary S Connery; Garrett M Fitzmaurice; Geetha Subramaniam; George E Woody; Roger D Weiss Journal: Drug Alcohol Depend Date: 2013-03-22 Impact factor: 4.492
Authors: Melannie Alexander; Meredith A Ray; James R Hébert; Shawn D Youngstedt; Hongmei Zhang; Susan E Steck; Richard K Bogan; James B Burch Journal: Sleep Date: 2016-07-01 Impact factor: 5.849
Authors: Alana Mercurio; Elizabeth R Aston; Kasey R Claborn; Katherine Waye; Rochelle K Rosen Journal: Subst Use Misuse Date: 2019-06-10 Impact factor: 2.164
Authors: Rachel L Gunn; Angela K Stevens; Lauren Micalizzi; Kristina M Jackson; Brian Borsari; Jane Metrik Journal: Exp Clin Psychopharmacol Date: 2020-03-05 Impact factor: 3.157
Authors: Kendall C Browne; Malki Stohl; Kipling M Bohnert; Andrew J Saxon; David S Fink; Mark Olfson; Magdalena Cerda; Scott Sherman; Jaimie L Gradus; Silvia S Martins; Deborah S Hasin Journal: Am J Psychiatry Date: 2021-08-19 Impact factor: 18.112
Authors: Elizabeth R Aston; Jane Metrik; Rochelle K Rosen; Robert Swift; James MacKillop Journal: Exp Clin Psychopharmacol Date: 2020-02-27 Impact factor: 3.157
Authors: Rachel Carmen Ceasar; Alex H Kral; Kelsey Simpson; Lynn Wenger; Jesse L Goldshear; Ricky N Bluthenthal Journal: Drug Alcohol Depend Date: 2020-11-23 Impact factor: 4.492
Authors: Ekaterina V Fedorova; Carolyn F Wong; Janna Ataiants; Ellen Iverson; Bridgid M Conn; Stephen E Lankenau Journal: Drug Alcohol Depend Date: 2021-02-22 Impact factor: 4.492